The store will not work correctly when cookies are disabled.
6,7-dihydro-2-(4-phenoxyphenyl)-1,4-dithiepin-1,1,4,4-tetraoxide
ID: ALA3958445
PubChem CID: 9799171
Max Phase: Preclinical
Molecular Formula: C17H16O5S2
Molecular Weight: 364.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S1(=O)C=C(c2ccc(Oc3ccccc3)cc2)S(=O)(=O)CCC1
Standard InChI: InChI=1S/C17H16O5S2/c18-23(19)11-4-12-24(20,21)17(13-23)14-7-9-16(10-8-14)22-15-5-2-1-3-6-15/h1-3,5-10,13H,4,11-12H2
Standard InChI Key: SMZPMKLLNJSJSF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
20.0853 -31.4166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0895 -30.5909 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.3723 -31.0001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1636 -28.0186 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5191 -28.7893 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.9124 -28.0193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7751 -29.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2624 -29.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5820 -29.9428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4408 -29.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9181 -30.6005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1365 -28.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1295 -27.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4111 -27.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6992 -27.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7102 -28.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4293 -29.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9793 -27.4016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2690 -27.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5504 -27.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8405 -27.8362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8495 -28.6627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5744 -29.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2813 -28.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 5 1 0
5 8 1 0
7 9 2 0
8 10 1 0
9 2 1 0
10 11 1 0
2 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
7 12 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.44 | Molecular Weight (Monoisotopic): 364.0439 | AlogP: 3.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 77.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.12 | CX LogD: 1.12 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.84 | Np Likeness Score: -0.44 |
References
1. (2002) 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor, |